Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F63U6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,296
Award facts
- Contract value 100% obligated
- $12,296.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,296.10 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. The contractor's established track record of delivering diverse pharmaceutical products through competitive federal procurement demonstrates its capability to meet complex medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F63U6?
SPE2DR26F63U6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F63U6 worth?
The government has obligated $12,296 on SPE2DR26F63U6.
Is contract SPE2DR26F63U6 an order under another contract?
Yes. SPE2DR26F63U6 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F63U6 competed?
The extent of competition for SPE2DR26F63U6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award